HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 183 filers reported holding HEALTH CATALYST INC in Q2 2022. The put-call ratio across all filers is 6.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,876 | -19.0% | 3,051 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $38,138 | +7.1% | 3,051 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $35,605 | +2.6% | 3,051 | -6.5% | 0.00% | 0.0% |
Q4 2022 | $34,686 | +9.6% | 3,263 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $31,651 | -33.1% | 3,263 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $47,281 | -44.5% | 3,263 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $85,262 | -83.7% | 3,263 | -75.3% | 0.00% | -57.1% |
Q4 2021 | $524,173 | -20.8% | 13,230 | 0.0% | 0.01% | -30.0% |
Q3 2021 | $661,632 | -3.6% | 13,230 | +7.0% | 0.01% | 0.0% |
Q2 2021 | $686,270 | +50.5% | 12,363 | +26.8% | 0.01% | +42.9% |
Q1 2021 | $455,867 | +3.6% | 9,747 | -3.6% | 0.01% | 0.0% |
Q4 2020 | $440,175 | +18.9% | 10,112 | 0.0% | 0.01% | +16.7% |
Q3 2020 | $370,099 | +25.5% | 10,112 | 0.0% | 0.01% | +20.0% |
Q2 2020 | $294,967 | +84.8% | 10,112 | +65.6% | 0.01% | +66.7% |
Q1 2020 | $159,646 | +66.8% | 6,105 | +121.4% | 0.00% | +50.0% |
Q4 2019 | $95,703 | -40.4% | 2,758 | -45.6% | 0.00% | -33.3% |
Q3 2019 | $160,541 | – | 5,074 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Norwest Venture Partners XI, LP | 876,045 | $32,063,000 | 100.00% |
Norwest Venture Partners XII, LP | 876,045 | $32,063,000 | 69.68% |
Nepsis Inc. | 197,178 | $7,217,000 | 3.46% |
Karani Asset Management LLC | 133,968 | $4,903,000 | 3.29% |
ADAMS STREET PARTNERS LLC | 201,548 | $6,639,000 | 1.75% |
HHR Asset Management, LLC | 412,423 | $15,095,000 | 1.50% |
Mesirow Financial Investment Management, Inc. | 9,510 | $348,000 | 1.49% |
ASHFORD CAPITAL MANAGEMENT INC | 342,500 | $12,536,000 | 1.49% |
Roubaix Capital, LLC | 31,889 | $1,167,000 | 1.38% |
Monarch Partners Asset Management LLC | 154,847 | $5,667,000 | 1.28% |